From the Medical Director

www.renalandurologynews.com SEPTEMBER/OCTOBER 2021 Renal & Urology News 1

Contents

SEPTEMBER/OCTOBER 2021 ■ VOLUME 20, ISSUE NUMBER 5

ONLINE

this month at renalandurologynews.com

Clinical Quiz

Test your knowledge by taking our latest quiz at renalandurologynews.com/ run-quiz

HIPAA Compliance

Read timely articles on various issues related to keeping protected health information secure.

Drug Information

Search a comprehensive drug database for prescribing and other information on more than 4000 drugs.

Job Board

Be sure to check our latest listings for professional openings across the United States.

News Coverage

Visit our website for daily reports on the latest developments in clinical research.

Urology

3 Enzalutamide vs AS Slows PCa Progression The drug increased the likelihood of a negative prostate biopsy at 1 year among men with low- and favorable intermediaterisk localized prostate cancer.

4 Encouraging Trial Results Reported for NMIBC Primary Chemoablation Patients treated with a mitomycin-containing reverse thermal gel had a complete response rate of 65% at 3 months.

12 NAC Underused for MIBC in Older Adults Neoadjuvant chemotherapy before radical cystectomy improves perioperative outcomes among patients aged 70 years or older.

20 Study Challenges ADT Use at PSA Relapse Delaying use of androgen deprivation therapy until metastasis has minimal impact on overall survival.

Nephrology

15 Ketogenic Diets Can Increase Renal Risks Potential dangers include accelerated loss of kidney function and exacerbation of metabolic acidosis.

15 Long-Term Kidney Transplant Outcomes Improving The 10-year graft and patient survival rates increased for patients who received deceased-donor and living-donor kidneys from 1996 to 2011.

21 Salt Substitute May Decrease Stroke Risk Patients at elevated risk for cardiovascular events who used a reduced-sodium salt had a 14% lower stroke risk.

29 AKI Tied to Arterial Stiffness Results support consideration of including arterial stiffness in risk prediction models for AKI and as a target for prevention or treatment of AKI, according to researchers.

We believe that patients will be receptive to this new treatment option, as there is currently nothing else approved as a primary treatment therapy. CALENDAR

Editor’s note: The listings below include dates and venues indicated by the sponsoring organizations on their websites. Some organizations have converted to all-virtual formats as a result of the pandemic. As this issue went to press, it was unclear whether other organizations will do the same.

American Society for Radiation Oncology (ASTRO)

Annual Meeting Chicago, IL October 24–27

American Society of Nephrology

Kidney Week Virtual November 2–7

Large Urology Group Practice Association

Annual Meeting Chicago, IL November 11–13

Society of Urologic Oncology

Annual Meeting Orlando, FL December 1–3

31

Departments

2 From the Medical Director Should active surveillance for prostate cancer be rebranded?

5 News in Brief FDA approves medication for pruritus in hemodialysis patients

31 Ethical Issues in Medicine Lessons from the way we deal with shopping carts

32 Practice Management Recruiting and retaining health care staff have gotten harder